Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
収録刊行物
-
- Cellular Signalling
-
Cellular Signalling 26 (5), 1030-1039, 2014-05
Elsevier BV